参考文献/References:
[1] Südhof TC. Towards an understanding of synapse formation[J]. Neuron, 2018, 100(2): 276-293.
[2] Selkoe DJ. Alzheimer's disease is a synaptic failure[J]. Science, 2002, 298(5594): 789-791.
[3] Schirinzi T, Madeo G, Martella G, et al. Early synaptic dysfunction in Parkinson's disease: Insights from animal models[J]. Mov Disord, 2016, 31(6): 802-813.
[4] Nachman E, Verstreken P. Synaptic proteostasis in Parkinson's disease[J]. Curr Opin Neurobiol, 2022, 72: 72-79.
[5] Longhena F, Faustini G, Spillantini MG, et al. Living in promiscuity: the multiple partners of Alpha-Synuclein at the synapse in physiology and pathology[J]. Int J Mol Sci, 2019, 20(1): 141.
[6] Samii A, Nutt JG, Ransom BR. Parkinson's disease[J]. Lancet, 2004, 363(9423): 1783-1793.
[7] Masuda-Suzukake M, Nonaka T, Hosokawa M, et al. Prion-like spreading of pathological α-synuclein in brain[J]. Brain, 2013, 136(Pt 4): 1128-1138.
[8] Bartels T, Choi JG, Selkoe DJ. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation[J]. Nature, 2011, 477(7362): 107-110.
[9] Yc W, Krainc D. α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies[J]. Nat Med, 2017, 23(2): 1-13.
[10] Yang W, Yu S. Synucleinopathies: common features and hippocampal manifestations[J]. Cell Mol Life Sci, 2017, 74(8): 1485-1501.
[11] Koga S, Sekiya H, Kondru N, et al. Neuropathology and molecular diagnosis of Synucleinopathies[J]. Mol Neurodegener, 2021, 16(1): 83.
[12] Zefirov AL. Vesicle cycle in the presynaptic nerve terminal[J]. Ross Fiziol Zh Im I M Sechenova, 2007, 93(5): 544-562.
[13] Schweizer FE, Ryan TA. The synaptic vesicle: cycle of exocytosis and endocytosis[J]. Curr Opin Neurobiol, 2006, 16(3): 298-304.
[14] Rizzoli SO. Synaptic vesicle recycling: steps and principles[J]. EMBO J, 2014, 33(8): 788-822.
[15] Pranke IM, Morello V, Bigay J, et al. α-Synuclein and Alps motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding[J]. J Cell Biol, 2011, 194(1): 89-103.
[16] Davidson WS, Jonas A, Clayton DF, et al. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes[J]. J Biol Chem, 1998, 273(16): 9443-9449.
[17] Middleton ER, Rhoades E. Effects of curvature and composition on α-synuclein binding to lipid vesicles[J]. Biophys J, 2010, 99(7): 2279-2288.
[18] Shen H, Pirruccello M, De Camilli P. SnapShot: membrane curvature sensors and generators[J]. Cell, 2012, 150(6): 1300, 1300.e1-2.
[19] Braun AR, Sevcsik E, Chin P, et al. α-Synuclein induces both positive mean curvature and negative Gaussian curvature in membranes. J Am Chem Soc, 2012, 134(5): 2613-2620.
[20] Westphal CH, Chandra SS. Monomeric synucleins generate membrane curvature[J].J Biol Chem, 2013, 288(3): 1829-1840.
[21] Sudhof TC. The synaptic vesicle cycle[J]. Annu Rev Neurosci, 2004, 27: 509-547.
[22] Chanaday NL, Cousin MA, Milosevic I, et al. The synaptic vesicle cycle revisited: new insights into the modes and mechanisms[J]. J Neurosci, 2019, 39(42): 8209-8216.
[23] Alabi AA, Tsien RW. Perspectives on kiss-and-run: role in exocytosis, endocytosis, and neurotransmission[J]. Annu Rev Physiol, 2013, 75: 393-422.
[24] Denker A, Rizzoli SO. Synaptic vesicle pools: an update[J]. Front Synaptic Neurosci, 2010, 2: 135.
[25] Becherer U, Rettig JP, docking. Priming,and release[J]. Cell Tissue Res, 2006, 326(2): 393-407.
[26] Rizo J, Xu J. The synaptic vesicle release machinery[J]. Annu Rev Biophys, 2015, 44: 339-367.
[27] Fusco G, Pape T, Stephens AD, et al. Structural basis of synaptic vesicle assembly promoted by α-synuclein[J]. Nat Commun, 2016, 7: 12563.
[28] Fouke KE, Wegman ME, Weber SA, et al. Synuclein regulates synaptic vesicle clustering and docking at a vertebrate synapse[J]. Front Cell Dev Biol, 2021, 9: 774650.
[29] Nemani VM, Lu W, Berge V, et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis[J]. Neuron, 2010, 65(1): 66-79.
[30] Scott D, Roy S. α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis[J]. J Neurosci, 2012, 32(30): 10129-10135.
[31] Huang M, Wang B, Li X, et al. α-Synuclein: A multifunctional player in exocytosis, endocytosis, and vesicle recycling[J]. Front Neurosci, 2019, 13: 28.
[32] Larsen K, Schmitz Y, Troyer MD, et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis[J]. J Neurosci, 2006, 26(46): 11915-11922.
[33] Martin LJ, Pan Y, Price AC, et al. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death[J]. J Neurosci, 2006, 26(1): 41-50.
[34] Bridi JC, Hirth F. Mechanisms of α-Synuclein induced synaptopathy in parkinson's disease[J]. Front Neurosci, 2018, 12: 80.
[35] Jena BP. Assembly and disassembly of SNAREs in membrane fusion[J]. Methods Cell Biol, 2008, 90: 157-182.
[36] Yoon TY, Munson M. SNARE complex assembly and disassembly[J]. Curr Biol, 2018, 28(8): R397-R401.
[37] Baker RW, Hughson FM. Chaperoning SNARE assembly and disassembly[J]. Nat Rev Mol Cell Biol, 2016, 17(8): 465-479.
[38] Bombardier JP, Munson M. Three steps forward, two steps back: mechanistic insights into the assembly and disassembly of the SNARE complex[J]. Curr Opin Chem Biol, 2015, 29: 66-71.
[39] Burré J, Sharma M, Tsetsenis T, et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro[J]. Science, 2010, 329(5999): 1663-1667.
[40] Gao V, Briano JA, Komer LE, et al. Functional and pathological effects of α-Synuclein on synaptic SNARE complexes[J]. J Mol Biol, 2022, 167714.
[41] Logan T, Bendor J, Toupin C, et al. α-Synuclein promotes dilation of the exocytotic fusion pore[J]. Nat Neurosci, 2017, 20(5): 681-689.
[42] Diao J, Burré J, Vivona S, et al. Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2[J]. Elife, 2013, 2: e00592.
[43] Choi BK, Choi MG, Jy K, et al. Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking[J]. Proc Natl Acad Sci U S A, 2013, 110(10): 4087-4092.
[44] Dalfó E, Barrachina M, Rosa JL, et al. Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease[J]. Neurobiol Dis, 2004, 16(1): 92-97.
[45] Calo L, Wegrzynowicz M, Santivañez-Perez J, et al. Synaptic failure and α-synuclein[J]. Mov Disord, 2016, 31(2): 169-177.
[46] Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis[J]. Nat Rev Mol Cell Biol, 2018, 19(5): 313-326.
[47] Mettlen M, Chen PH, Srinivasan S, et al. Regulation of Clathrin-Mediated endocytosis[J]. Annu Rev Biochem, 2018, 87: 871-896.
[48] Wang L, Das U, Scott DA, et al. α-synuclein multimers cluster synaptic vesicles and attenuate recycling[J]. Curr Biol, 2014, 24(19): 2319-2326.
[49] Sun J, Wang L, Bao H, et al. Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling[J]. Proc Natl Acad Sci USA, 2019, 116(23): 11113-11115.
[50] Medeiros AT, Soll LG, Tessari I, et al. α-Synuclein dimers impair vesicle fission during Clathrin-Mediated synaptic vesicle recycling[J]. Front Cell Neurosci, 2017, 11: 388.
[51] Hallacli E, Kayatekin C, Nazeen S, et al. The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability[J]. Cell, 2022, 185(12): 2035-2056, e33.